Complete AI Training
Start for Free

Your job's AI kit

Get your AI kit

Tell us who you are and what you do. We show you your kit right away and email you the link: skills, prompts, AI agents, MCP servers and courses for your job.

500+ jobs ready, and we make a kit for any other job. No payment needed to look.

Share

AI news ·

Generative AI in Healthcare Market to Reach $39.8B by 2035 at 28% CAGR, Driven by Admin Relief, Funding and ML Advances

GenAI in healthcare set to climb from $3.3B to $39.8B by 2035 (28% CAGR), driven by admin strain and funding. Lead with outcomes: $150B admin savings, up to 85% fewer errors.

Generative AI in Healthcare: 2025 Market Outlook and Go-To-Market Moves for Healthcare Marketers

The generative AI in healthcare market is valued at USD 3.3 billion and is projected to reach USD 39.8 billion by 2035, at a 28% CAGR. Growth is fueled by administrative strain, increased funding, and steady AI/ML improvements that translate into real cost and time savings.

Operational pain points are clear: clinical inefficiencies, rising costs, workforce shortages, and burnout. In Medscape's 2024 Physician Burnout and Depression Report, 49% of physicians reported burnout, driven by administrative burdens (62%) and long hours (41%).

Where the value shows up now

Generative AI targets both clinical and operational outcomes. The upside is tangible:

  • Administrative automation can save ~USD 150 billion annually across the sector.
  • Studies suggest up to 85% reduction in diagnostic errors.
  • 21% reduction in nursing overtime; potential savings of ~USD 469,000 over three years per hospital.

What buyers are prioritizing

  • Clinical-based purpose holds the largest current share due to direct impact on patient care and decision support.
  • Treatment leads by application and is expected to remain the largest segment.
  • Healthcare providers drive the bulk of revenues today and are set to grow faster than other end-users.

What the market is buying

  • Technology/platform offerings dominate with close to 75% share of the current market.
  • Services are projected to grow at a relatively higher CAGR as deployments scale and customization needs increase.

Market structure and buyer power

  • More than 45% of vendors are mid-sized; 79% are headquartered in North America.
  • Over 85% offer technology/platforms; 27% serve both healthcare providers and P/B companies.
  • Partnership momentum is strong, with ~90% of deals inked in the last two years.
  • Buyer bargaining power is very high, so initiatives require careful evaluation of vendor durability, data rights, and roadmap fit.

Segmentation snapshot

  • Purpose: Clinical-based; System-based
  • Type of offering: Technology/Platform; Service
  • Application area: Drug discovery and development; Diagnosis; Treatment; Administrative tasks; Other
  • End-user: Pharmaceutical and life science companies; Healthcare providers; Other end-users
  • Regions: North America; Europe; Asia-Pacific; Middle East and North Africa; Latin America

Regional outlook

North America currently holds the largest share. Asia-Pacific is expected to grow at a relatively high CAGR through 2035.

Partnerships worth tracking

  • NVIDIA × Genentech
  • Insilico Medicine × Inimmune
  • OpenAI × Moderna
  • Amazon Web Services × Pfizer
  • Suki × Ascension Saint Thomas
  • Abridge × Emory Healthcare
  • Google × China Medical University Hospital

Companies to watch

  • Amazon Web Services, C3 AI, Exscientia, Google, Huma, IBM, Iktos, LeewayHertz, Medical IP, Microsoft, NVIDIA, OpenAI, Oracle, PhamaX, Syntegra

Why this matters for healthcare marketing leaders

  • Lead with outcomes: quantify admin savings, error reduction, and clinical throughput in your messaging and ROI models.
  • Segment by buyer reality: provider priorities (care quality, clinician time, throughput) differ from pharma/life sciences (R&D speed, target ID, trial design).
  • Positioning matters: if you sell a platform, emphasize integration, data stewardship, and extensibility; if you sell services, lean into speed-to-value and domain expertise.
  • Publish proof: case studies tied to treatment impact, documentation automation, and cost avoidance will accelerate buying cycles.
  • Partner early: alliances with EHRs, imaging vendors, and cloud providers shorten procurement and integration timelines.
  • Address governance up front: be explicit about privacy, security certifications, bias testing, and model transparency to clear compliance hurdles.

90-day action plan

  • Map 3-5 high-friction workflows (e.g., prior auth, note summarization, imaging triage) and attach cost/time baselines.
  • Build a simple ROI calculator using the savings ranges above to qualify pipeline and prioritize pilots.
  • Stand up two proofs of value: one administrative, one clinical-adjacent; define success thresholds pre-deployment.
  • Codify data and model governance FAQs to preempt legal and IT security objections.

Risk and compliance guardrails

As adoption scales, strong governance is non-negotiable: data privacy, bias mitigation, and transparency must be embedded in product design and vendor contracts. Align with institutional review, audit requirements, and regional regulations before expansion.

Geographic detail

  • North America: US, Canada
  • Europe: Germany, UK, France, Spain, Switzerland, The Netherlands, Rest of Europe
  • Asia-Pacific: China, Japan, South Korea, Singapore, India, Rest of Asia-Pacific
  • Middle East and North Africa: Israel, UAE, Rest of MENA
  • Latin America: Brazil, Rest of Latin America

Want the full breakdown?

Access the report: Generative AI in Healthcare Market: Industry Trends and Global Forecasts to 2035.

Reference on physician burnout: Medscape 2024 Physician Burnout and Depression Report.

Upskill your team

If you lead marketing in healthcare and need practical fluency in AI for go-to-market, explore:

Share